share_log

Avalo Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven Boyd(4.99%),Armistice Capital, LLC(4.7%)

SEC announcement ·  Jun 27, 2023 18:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more